Thermo Fisher Scientific Reports Strong Q3 Earnings and Revenue Growth
Thermo Fisher Scientific (TMO) reported third-quarter Non-GAAP earnings per share (EPS) of $6.68, exceeding estimates by $0.28. The company also achieved revenue of $12.14 billion for the quarter, surpassing expectations by $190 million and growing 9% year-over-year compared to $11.12 billion in Q3 2025. The results reflect strong organic growth across Thermo Fisher's business segments, driven by continued demand in life sciences research and diagnostic testing. The performance highlights the company’s resilience amid macroeconomic challenges and reinforces its position as a leader in scientific innovation and healthcare solutions.
Tickers: $TMO
Topics: earnings financial performance revenue growth
Read the full article at Seeking Alpha
Part of the story Parke Bancorp Reports Strong Third Quarter 2026 Earnings Growth (21 articles)